Home » Newsletters » BioWorld

BioWorld

June 30, 1993

View Archived Issues

GREENWICH RAISES $11.8 MILLION IN STOCK SALE

CALBIOCHEM MOVES ACTIVITIES

LILLY TAKES OVER CENTORX

MASOPROCOL REVERSES MULTIPLE DRUG RESISTANCE

HOTH JOINS CELL GENESYS

IMMUNOGEN BEGINS TRIALS

BROAD PROCESS PATENT FOR 'FORCED EVOLUTION'

PROTEIN POLYMER GRANTS LICENSE TO CELLCO

RECIPE FOR IMPROVING ON NATURE

COLLABORATION TO RESEARCH OSTEOPOROSIS

ID BIOMED TEAMS WITH TM TECHNOLOGIES

HEMACARE REGISTRATION DECLARED EFFECTIVE

TRANSDERMAL GLUCOSE MONITORING PATENT ALLOWED

CELLEX DISTRIBUTION PACT WITH TOSOH

BTG'S GROWTH HORMONE LAUNCHED IN JAPAN

BRITISH BIO RESTRUCTURES RELATIONSHIP WITH TECHNE

RAC APPROVES AIS GENE THERAPY PROTOCOL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...